Live Events

3rd Annual International Neuroscience Symposium - Bench to Bedside 2026

March 12 - 13, 2026
Promotion Code: Apply
When
March 12 - 13, 2026
07:30 AM - 3:30 PM
Where
AdventHealth Nicholson Center
404 Celebration Place
Celebration, Florida
Presenter(s)
Anwar Ahmed, MD; Kirk Erickson, PhD; Anita Fletcher, MD; Ira Goodman, PhD; Selim R. Benbadis, MD; Stacey L. Clardy, MD, PhD; Nathan E. Crone, MD; Divyanshu Dubey, MD, FAAN, FANA; Ricardo A. Hanel, MD, PhD; Nikolaus McFarland, MD, PhD; Stephen E. Nadeau, MD; Serhat Okar, MD, PhD; Laurie H. Sanders, PhD; Holly Skinner, DO; Kiminobu Sugaya, PhD; Chad J. Swanson, PhD; Kristine Wilckens, PhD
Contact
Haila Bear
407-303-4177
Haila.Bear@Adventhealth.com
Details

The 3rd Annual International Neuroscience Symposium – Bench to Bedside 2026 will unite leading researchers and clinicians to explore groundbreaking advances in Alzheimer’s disease, Parkinson’s disease, sleep disorders, epilepsy, neurosurgery, and neuroinflammation. In a dynamic, respectful environment, participants will share cutting-edge research, clinical insights, and innovative strategies bridging the gap between discoveries and patient care to advance the understanding, prevention, and treatment of neurological disorders.

Featuring engaging presentations, interactive Q&A sessions, and opportunities to connect with experts, this event offers a unique platform to discover new strategies and be part of the conversation, shaping the future of neuroscience.

PLEASE NOTE: You have to register and complete the requirements for continuing education credit.

Event Objectives:

  • Describe current research advancements and clinical approaches in Alzheimer’s disease, Parkinson’s disease, sleep disorders, epilepsy, neurosurgery, and neuroinflammation.
  • Analyze the connections between laboratory discoveries and their translation into effective patient care strategies.
  • Evaluate emerging diagnostic innovations and therapeutic interventions for neurological disorders.
  • Discuss practical insights gained through meaningful dialogue with experts that can be applied in both clinical and research settings. 
  •  Apply new knowledge and strategies to improve patient outcomes and advance neuroscience practice.

Completion Requirements: To receive continuing education credit commensurate with the credit awarded for this live event, the participant must:

  • Attend the events.
  • Complete and submit the on-line evaluation.

Certificates of Completion: will be available to print immediately upon finishing the completion requirements. You are encouraged to print and save your certificate for your portfolio as required by your licensing body. Interdisciplinary accredited activities, activities having multiple accreditors, will be listed individually on the Certificate of Completion.

Non-Endorsement of Products: echelon®, as an accredited provider, has demonstrated proficient experience and viable resources to provide for valid and reliable evaluation of CE activities. The accuracy of the facts and opinions contained in this activity are the responsibility of the author(s) and do not necessarily reflect those of echelon® or its sponsors. Practitioners should consult primary resources, state regulations, and their healthcare facility policies and procedures for specific application of said content to their local situation. echelon® does not imply that there is real or implied endorsement of any product, service, or company neither referred to in this activity nor of any company subsidizing costs related to this activity. All information contained in this activity is for educational purposes only.

Electronic Record Retention: All activity records are kept on file for a minimum of six (6) years.

echelon® also chooses full disclosure with each activity to report any author conflicts of interest or commercial affiliation or support in conjunction with any activity.

Educational Health Care Team Members and Course Author Conflict of Interest: There have been no conflicts of interest disclosed by planners, authors, or presenters; nor has there been disclosure of any relevant financial relationships with any commercial companies or their products pertaining to this activity.